RXRX icon

Recursion Pharmaceuticals
RXRX

Overview Fund Activity

328 hedge funds and large institutions have $1.55B invested in Recursion Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 109 increasing their positions, 90 reducing their positions, and 60 closing their positions.

Holders
328
Holders Change
-5
Holders Change %
-1.5%
% of All Funds
4.4%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
57
Increased
109
Reduced
90
Closed
60
Calls
$43.7M
Puts
$32.6M
Net Calls
+$11.1M
Net Calls Change
+$4.51M

Top Buyers

1
BlackRock
1
BlackRock
New York
$144M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$183M
3
Norges Bank
3
Norges Bank
Norway
$16M
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$39.4M
5
First Trust Advisors
5
First Trust Advisors
Illinois
$9.51M

Top Sellers

1
State Street
1
State Street
Massachusetts
$56.6M
2
AIM
2
ARK Investment Management
Florida
$167M
3
UBS AM
3
UBS AM
Illinois
$23.4M
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$172K
5
LCM
5
Laurion Capital Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$6.98M 1,378,915 +93,953 +7%
VAS
27
Vestmark Advisory Solutions
Massachusetts
$6.78M 1,339,139 +632,900 +90%
Citadel Advisors
28
Citadel Advisors
Florida
$6.65M 1,314,552 -1,341,159 -51%
NL
29
Nuveen LLC
North Carolina
$6.2M 1,225,658 -686,962 -36%
Two Sigma Investments
30
Two Sigma Investments
New York
$5.91M 1,167,813 +15,187 +1%
Barclays
31
Barclays
United Kingdom
$5.89M 1,164,689 +573,683 +97%
JF
32
Jump Financial
Illinois
$5.83M 1,151,201 +558,848 +94%
Goldman Sachs
33
Goldman Sachs
New York
$5.72M 1,131,218 -364,645 -24%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$5.47M 1,081,203 +217,979 +25%
CFM
35
Comprehensive Financial Management
California
$4.77M 941,895 – –
IEFM
36
IQ EQ Fund Management
Ireland
$4.61M 911,085 +523,848 +135%
Millennium Management
37
Millennium Management
New York
$3.74M 739,408 +237,300 +47%
Capital Fund Management (CFM)
38
Capital Fund Management (CFM)
France
$3.65M 720,526 +513,258 +248%
LIP
39
Liontrust Investment Partners
United Kingdom
$3.55M 702,386 +107,331 +18%
NFGH
40
Nan Fung Group Holdings
Hong Kong
$3.36M 664,610 – –
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$3.21M 633,403 +572,497 +940%
XT
42
XTX Topco
Cayman Islands
$3.19M 631,206 +631,206 New
PBPIA
43
Pivotal bioVenture Partners Investment Advisor
California
$3.01M 595,518 – –
Swiss National Bank
44
Swiss National Bank
Switzerland
$2.86M 566,200 +82,900 +17%
HF
45
HRT Financial
New York
$2.75M 544,159 +544,159 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$2.62M 517,255 +158,080 +44%
VF
47
Virtu Financial
New York
$2.27M 449,092 +415,056 +1,219%
CM
48
Caption Management
Oklahoma
$2.13M 420,801 +420,801 New
Ensign Peak Advisors
49
Ensign Peak Advisors
Utah
$2.08M 410,286 – –
Lazard Asset Management
50
Lazard Asset Management
New York
$2.05M 404,364 -101,774 -20%
1
2
3 4 5